News
-
-
COMMUNIQUÉ DE PRESSE
Oxurion kondigt de ondertekening aan van een bindende overeenkomst tot overname van de Franse biometriespecialist Axiodis CRO
Oxurion NV erwirbt 72% des Aktienkapitals von Axiodis CRO für 468.000 EUR, um das Unternehmen auf 650.000 EUR zu bewerten. Transaktionsschluss erwartet bis Ende Juni 2025 -
COMMUNIQUÉ DE PRESSE
Oxurion announces the signing of a binding agreement to acquire French biometrics specialist Axiodis CRO
Oxurion NV to acquire 72% of Axiodis CRO shares for €468,000, valuing the company at €650,000. Deal expected to close by June 2025. Axiodis CRO specializes in clinical biometrics, offers integrated services for clinical trials, and aims for revenue growth -
-
-
-
-
-
-